Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nath Bio-Genes (India) Ltd. market cap is 3.78B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nath Bio-Genes (India) Ltd. 52 week high is 244.60 as of April 25, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nath Bio-Genes (India) Ltd. 52 week low is 159.00 as of April 25, 2024.
Nath Bio-Genes (India) Ltd. stock price today is 200.00.
Nath Bio-Genes (India) Ltd. stock price yesterday was 198.25.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nath Bio-Genes (India) Ltd.’s P/E ratio is 9.96.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nath Bio-Genes (India) Ltd. P/B ratio is 0.6262.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nath Bio-Genes (India) Ltd.'s EBITDA is 9.51.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nath Bio-Genes (India) Ltd. 50-day moving average is 194.80.
Nath Bio-Genes (India) Ltd. has 433 employees.